Gene search

Sequence information

Select Gene Cds Cds_length GC_content Pep Pep_length
Vifa2g04475 ATGGCAACAACGGCTATATTTCTCACCATTGCATGCCTCACATACTTCACCACCATACTCATCATAACACATGCTTCAACAACAACAACAAACAACGAAATCCAGGCCTTGACAACCTTCAAACTAAACCTCCTCGACCCACTCAACTCACTAACAACCTGGAACACATCAACCCCATCACCACCATGCGACTGGCACGGCATTCTCTGTTCCAACAACAGAGTCCACCAAATACGCTTACCTCGTCTTCAACTATCCGGCGCCATCTCTTCATCACTCTCCAAACTCACACAACTCCGCAAACTAAGTCTCCATTCCAACAACCTCATTTCCTCAATCCCTCCCTCTCTTTCTCAATGTCTCTTCCTCCGCGCCATTTATCTTCACAACAACTCCCTCTCTGGAAACATCCCTCCCTCACTTCTCAACCTCACCAACCTTCAGGTTCTTAACTTTGCTGCTAACTTTCTCTCCGGCACTATCCCAAACCGTCTCTCTAACTCCCTACGCATCCTCGACCTTTCCTCCAACTCATTCACCGGCAACATCCCAGGGAACTTTACCTCCAACTCCCAGCTTCAACTCATCAACCTCTCTCACAATCGCCTAACAGGCCAAATACCTGTTACACTTGGAGCTTTACAACAGCTGCAATATATGTGGCTAGACAACAACCGTCTCCATGGAACATTACCTTCTGCTATATCAAACTGCTCCTCTATGGTGCACCTCAGCATAGAGGAAAATTCCATTGGCGGGTTGATCCCTTCTACCATAGGGACAATGCCAAAGCTTCAAGTGCTGTCACTTTCCCTTAATCAACTTTCTGGTTTTGTCCCCACAACCCTCTTTTGCAATCAAAACAACAAACACAATAATACTCTTCGAATTCTTCAGCTTGGCTTTAATATGCTCACGGGTATTTCGAATCCGCCAAATGGAAAATGTGATAATCATTTTTTGGAGATTCTAGACCTTAAAGAGAATCACATTATTCAATCTTTGTTTCCTTCTTGGTTGACCAATGTGAAATCTTTGAGGACTCTTGATCTCTCTGGAAACTCTTTTTCAGGCTATCTGCCTCGAGATATTGGAGATCTTTTCTTGTTGGAAGAGTTGAGACTTTCTGATAATTCGTTATCCGGTGTTGTTCCGAGTAGTATTGTGGAATGTAGTTTGTTGAAGGTTCTTGATCTTCGAAGGAATCGATTCTCGGGTCTTGTTCCTTATTTCGTTGGAGAGTTGAAGAGTTTGAAGGAGTTATCTCTTGGTGGTAACTTTTTTACTGGTTTGATTCCAAAGAGTTATGGAGGTCTTTATGAGTTAGAGATTTTGGATTTAAGCAACAATAAGCTGAATGGGGTTTTGCCTTTGGAGATTATGCAGTTAGGAAACTTGGGTGTTTTGAATCTCAGCAATAATAGATTCTCTGGTCAAGTTTCGTATCGAATTGGAGGCTTAAAAAGTTTGCAGGTTCTTAATTTGAGCCAATGTGGGTTTTCTGGTAGTGTTCCATCTACACTTGGGAGTTTGATGAAACTGAGGGTGTTGGATTTAAGCAAACAAAATCTTTCAGGTGAGATACCTGTGGAGGTTTTCGGATTACCTAGTTTGGAAGTTGTGGCACTTGATGGAAACAGTTTGAGTGGTTCTGTTCCTGAGGGTTTCAGCAGCATTGTTAGTTTAAGGTATCTTAATCTTAGTTTCAATGATTTTGTTGGCAACATTCCAACAACTTATGGTTTTCTAAGTTCGTTGGTTGTTCTTTCTTTGTCTCACAATTTCATTTCTGGTTCAATACCTAATGAGATTGGTGGTTGTTCTCAACTTGAAGTGCTTCAGCTTCAATCGAATCGGTTAGTAGGTAACATCGTTCCGAGTGTTATCTCTCACCTTACTCGTTTAAAGGAGCTGAGTTTAGGAAACAATGGACTCAAAGGTGAAATCCCAGATGAGATTTCCAAGTGTTCTTCTTTGAACTCACTTGATTTGAATGGTAATCACTTAACCGGTCACATACCGCTATCCTTGTCCAAGTTATCAAATTTGAAGGCTTTGAATCTGTCTTCAAATCAATTGACAGGAGAAATTCCAGTTGATCTTTGGCGCATATCCGGTTTGAAGTACTTAAATGTTTCCAACAACGACCTCGAGGGTGAGATTCCACAAATGCTGAGTTCTAGATTCAATGACCCTTCTGTGTTTGCAATGAACAAGAGGCTATGTGGGAAACCATTGCATAGAGATTGTGCAAAAGCGAGAAGACGAAAGAGAAAAAGGCTAATAATCATCATAGGTGTTGCAGTTGCAGGACTATGCTTTCTAGCATTGTTTTGTTGTGGCTATGTTTACAGTCTTTTAAGGTGGCGAAAGAAGCTTCGAGAAGGAGTAACAGGCGAGAAGAAACGTAGCTCAACAAGTGCAGGCTCAAATGGAGAAAGAAACAGTCGAGGAAGCGGTGAAAACGGAGGACCAAAGTTAATAGTCTTCAACAACAAAATCACATACGCCGAAACACTAGAAGCAACAAGAAACTTCGATGAAGAAAACGTTCTAAGCAGAGGAAAACACGGACTTGTCTTCAAAGCCTCGTATCAAGATGGAATGGTTCTATCAATTCGTAGACTTCCAAACGGATCAACATTGATAGAAGAAAACACATTCCGCAAAGAAGCAGAATCGTTAGGCAAAGTTAAGCATCGAAACTTAACAGTTCTACGCGGCTATTATGCAGGACCACCACCTGATGTAAGACTACTAGTCTACGACTACATGCCAAATGGAAATCTAGGTACATTGCTTCAAGAAGCTTCGCAACAAGACGGTCATGTTTTGAATTGGCCAATGCGTCATTTAATCGCACTAGGCATTGCTCGTGGATTGGGTTTTCTACACTCTGTTGAAATTGTTCATGGCGATGTTAAGCCACAGAATGTTCTTTTTGATGCTGATTTTGAAGCACATTTATCCGAATTTGGGCTAGACCGGTTAACAATGGTTAGTATCCCTACAGAATTAGCAGAGTCGTCGTCTTCAACAACAATCGCAGTTGGTTCGTTGGGTTATGTCGCGCCAGAAGCTGTGCTAACAGGACAGGTGACAAAGGAAGGAGATATATATAGTTTCGGGATAGTGTTGTTGGAGATACTGACAGGAAGAAAAGCTGTTATGTTTACGGGTCAAGACGAAGATATAGTGAAATGGGTGAAGAAACAGTTACAAAAAGGTTTGATTTCGGAGCTGTTGGAACCTGGTTTGCTTGAGATTGATCAGGAATCATCAGAATGGGAAGAGTTTTTGTTAGGTGTTAAGGTTGCACTTCTTTGCACAGCACATGATCCTCTTGATAGACCTTCTATTAATGATATTGTTTTCATGCTTGAAGGTTGTCGTGTTGGACCTGATATACCTTCCTCTGCTGACCCAACCACACTACCTTCACCTGTTTCTTGA 3453 0.417 MATTAIFLTIACLTYFTTILIITHASTTTTNNEIQALTTFKLNLLDPLNSLTTWNTSTPSPPCDWHGILCSNNRVHQIRLPRLQLSGAISSSLSKLTQLRKLSLHSNNLISSIPPSLSQCLFLRAIYLHNNSLSGNIPPSLLNLTNLQVLNFAANFLSGTIPNRLSNSLRILDLSSNSFTGNIPGNFTSNSQLQLINLSHNRLTGQIPVTLGALQQLQYMWLDNNRLHGTLPSAISNCSSMVHLSIEENSIGGLIPSTIGTMPKLQVLSLSLNQLSGFVPTTLFCNQNNKHNNTLRILQLGFNMLTGISNPPNGKCDNHFLEILDLKENHIIQSLFPSWLTNVKSLRTLDLSGNSFSGYLPRDIGDLFLLEELRLSDNSLSGVVPSSIVECSLLKVLDLRRNRFSGLVPYFVGELKSLKELSLGGNFFTGLIPKSYGGLYELEILDLSNNKLNGVLPLEIMQLGNLGVLNLSNNRFSGQVSYRIGGLKSLQVLNLSQCGFSGSVPSTLGSLMKLRVLDLSKQNLSGEIPVEVFGLPSLEVVALDGNSLSGSVPEGFSSIVSLRYLNLSFNDFVGNIPTTYGFLSSLVVLSLSHNFISGSIPNEIGGCSQLEVLQLQSNRLVGNIVPSVISHLTRLKELSLGNNGLKGEIPDEISKCSSLNSLDLNGNHLTGHIPLSLSKLSNLKALNLSSNQLTGEIPVDLWRISGLKYLNVSNNDLEGEIPQMLSSRFNDPSVFAMNKRLCGKPLHRDCAKARRRKRKRLIIIIGVAVAGLCFLALFCCGYVYSLLRWRKKLREGVTGEKKRSSTSAGSNGERNSRGSGENGGPKLIVFNNKITYAETLEATRNFDEENVLSRGKHGLVFKASYQDGMVLSIRRLPNGSTLIEENTFRKEAESLGKVKHRNLTVLRGYYAGPPPDVRLLVYDYMPNGNLGTLLQEASQQDGHVLNWPMRHLIALGIARGLGFLHSVEIVHGDVKPQNVLFDADFEAHLSEFGLDRLTMVSIPTELAESSSSTTIAVGSLGYVAPEAVLTGQVTKEGDIYSFGIVLLEILTGRKAVMFTGQDEDIVKWVKKQLQKGLISELLEPGLLEIDQESSEWEEFLLGVKVALLCTAHDPLDRPSINDIVFMLEGCRVGPDIPSSADPTTLPSPVS 1150
       

Annotation information

Select Seq ID Length Analysis Description Start End IPR GO
Vifa2g04475 1150 SUPERFAMILY L domain-like 31 382 - -
Vifa2g04475 1150 ProSiteProfiles Leucine-rich repeat profile. 98 120 IPR001611 GO:0005515
Vifa2g04475 1150 Pfam Protein kinase domain 848 1123 IPR000719 GO:0004672|GO:0005524|GO:0006468
Vifa2g04475 1150 Gene3D Ribonuclease Inhibitor 311 390 IPR032675 -
Vifa2g04475 1150 FunFam Leucine-rich repeat receptor protein kinase EMS1 336 435 - -
Vifa2g04475 1150 FunFam LRR receptor-like serine/threonine-protein kinase ERECTA 30 189 - -
Vifa2g04475 1150 SMART serkin_6 846 1126 IPR000719 GO:0004672|GO:0005524|GO:0006468
Vifa2g04475 1150 Gene3D Ribonuclease Inhibitor 480 759 IPR032675 -
Vifa2g04475 1150 FunFam LRR receptor-like serine/threonine-protein kinase GSO1 461 754 - -
Vifa2g04475 1150 ProSiteProfiles Leucine-rich repeat profile. 441 462 IPR001611 GO:0005515
Vifa2g04475 1150 MobiDBLite consensus disorder prediction 802 818 - -
Vifa2g04475 1150 FunFam LRR receptor-like serine/threonine-protein kinase ERECTA 208 308 - -
Vifa2g04475 1150 SUPERFAMILY RNI-like 315 621 - -
Vifa2g04475 1150 PANTHER LEUCINE-RICH REPEAT RECEPTOR-LIKE PROTEIN KINASE FAMILY PROTEIN-RELATED 360 1127 - -
Vifa2g04475 1150 SUPERFAMILY L domain-like 582 728 - -
Vifa2g04475 1150 Pfam Leucine rich repeat 513 572 IPR001611 GO:0005515
Vifa2g04475 1150 Pfam Leucine rich repeat 394 452 IPR001611 GO:0005515
Vifa2g04475 1150 Pfam Leucine rich repeat 321 380 IPR001611 GO:0005515
Vifa2g04475 1150 Pfam Leucine rich repeat 168 227 IPR001611 GO:0005515
Vifa2g04475 1150 Pfam Leucine rich repeat 609 669 IPR001611 GO:0005515
Vifa2g04475 1150 Gene3D Phosphorylase Kinase; domain 1 821 924 - -
Vifa2g04475 1150 MobiDBLite consensus disorder prediction 798 824 - -
Vifa2g04475 1150 Pfam Leucine Rich repeat 680 696 IPR001611 GO:0005515
Vifa2g04475 1150 Pfam Leucine rich repeat N-terminal domain 31 71 IPR013210 -
Vifa2g04475 1150 Gene3D Transferase(Phosphotransferase) domain 1 925 1134 - -
Vifa2g04475 1150 PRINTS Leucine-rich repeat signature 680 693 - -
Vifa2g04475 1150 PRINTS Leucine-rich repeat signature 442 455 - -
Vifa2g04475 1150 SUPERFAMILY Protein kinase-like (PK-like) 826 1138 IPR011009 -
Vifa2g04475 1150 ProSiteProfiles Protein kinase domain profile. 846 1136 IPR000719 GO:0004672|GO:0005524|GO:0006468
Vifa2g04475 1150 FunFam Putative LRR receptor-like serine/threonine-protein kinase 810 924 - -
Vifa2g04475 1150 ProSitePatterns Serine/Threonine protein kinases active-site signature. 969 981 IPR008271 GO:0004672|GO:0006468
Vifa2g04475 1150 SMART LRR_sd22_2 214 240 - -
Vifa2g04475 1150 SMART LRR_sd22_2 439 460 - -
Vifa2g04475 1150 SMART LRR_sd22_2 415 436 - -
Vifa2g04475 1150 SMART LRR_sd22_2 292 313 - -
Vifa2g04475 1150 SMART LRR_sd22_2 632 655 - -
Vifa2g04475 1150 SMART LRR_sd22_2 680 701 - -
Vifa2g04475 1150 SMART LRR_sd22_2 96 115 - -
Vifa2g04475 1150 SMART LRR_sd22_2 583 598 - -
Vifa2g04475 1150 Gene3D Ribonuclease Inhibitor 29 190 IPR032675 -
Vifa2g04475 1150 Gene3D Ribonuclease Inhibitor 391 479 IPR032675 -
Vifa2g04475 1150 SMART LRR_typ_2 367 391 IPR003591 -
Vifa2g04475 1150 SMART LRR_typ_2 487 510 IPR003591 -
Vifa2g04475 1150 SMART LRR_typ_2 583 607 IPR003591 -
Vifa2g04475 1150 SMART LRR_typ_2 439 463 IPR003591 -
Vifa2g04475 1150 SMART LRR_typ_2 680 704 IPR003591 -
Vifa2g04475 1150 SMART LRR_typ_2 144 168 IPR003591 -
Vifa2g04475 1150 SMART LRR_typ_2 632 656 IPR003591 -
Vifa2g04475 1150 SMART LRR_typ_2 535 558 IPR003591 -
Vifa2g04475 1150 SMART LRR_typ_2 343 366 IPR003591 -
Vifa2g04475 1150 SMART LRR_typ_2 415 438 IPR003591 -
Vifa2g04475 1150 SMART LRR_typ_2 262 285 IPR003591 -
Vifa2g04475 1150 SMART LRR_typ_2 96 120 IPR003591 -
Vifa2g04475 1150 SMART LRR_typ_2 214 238 IPR003591 -
Vifa2g04475 1150 FunFam LRR receptor-like serine/threonine-protein kinase RPK2 925 1135 - -
Vifa2g04475 1150 Gene3D Ribonuclease Inhibitor 191 310 IPR032675 -
       

Duplication type information

Select Gene Chromosome Start End Duplicated_type
Vifa2g04475 Vifa-Chr2 1312804052 1312807504 Dispersed/Transposed
       

Functional genes information

Select Gene Gene_start Gene_end Function Ath_gene Identity(%) E-value Score
Vifa2g04475 8 1149 Receptor kinase-like Gene Family AT4G36180 61.512 0.0 1280
       

Transcription factors information

Select Regulatory Factors Family Gene Hmm_acc Hmm_name E_value Clan
PK RLK-Pelle_LRR-VII-3 Vifa2g04475 Pkinase 1.7e-30 CL0016
       

Pathway information

Select Query KO Definition Second KO KEGG Genes ID GHOSTX Score
Vifa2g04475 - - gmx:100801571 1568.52